April 1 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it had sued ... Healthcare & Pharmaceuticalscategory ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Eli Lilly is currently about three years ahead of other drugmakers developing pills, including Pfizer, AstraZeneca, Roche, ...

A new kind of pharma-telehealth partnership has come under scrutiny over concerns that such an arrangement could lead to ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Recent health developments spotlight China's push in brain chip trials, Corcept's successful ovarian cancer drug study, Lilly ...

With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA).As the company's third R&D centre ...